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Background. There is evidence that patients with schizophrenia beneﬁt from standard cognitive behaviour therapy
(CBT) only if active techniques are used (‘ full therapy ’). By contrast, attending sessions but not proceeding beyond
engagement and assessment strategies (‘partial therapy ’), or simply not attending sessions (‘no therapy ’), is not
associated with better outcomes. The factors leading to full therapy are unknown. We hypothesized that patients’
initial ideas about the nature and extent of their problems would predict use of CBT. A match between patients’
views of their problems and the principles underlying treatment would lead to better outcomes.
Method. Ninety-two patients with a recent relapse of psychosis completed the Illness Perception Questionnaire
(IPQ) before receiving CBT. We examined whether their illness perceptions predicted the take-up of therapy.
Results. Patients who did not attend sessions believed their problems would not last as long as those who attended
them. Those who attended sessions but did not proceed to full therapy had a lower sense of control over their
problems and a more biological view of their causes. Patients who took up full therapy were more likely to attribute
the cause of their problems to their personality and state of mind. The take-up of therapy was predicted neither by
levels of psychiatric symptoms nor by insight.
Conclusions. People with psychosis who have psychologically orientated views of their problems, including the
potential to gain control over them, may be more likely to engage fully and do well with standard CBT for psychosis,
irrespective of the severity of their problems.
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Introduction
Many people with health problems do not take up
oﬀers of treatment. For instance, after a heart attack
a majority do not attend rehabilitation programmes
despite the established beneﬁts (e.g. Lane et al. 2001).
Health psychologists have emphasized that responses
to a given condition, including adherence to treatment
and overall outcomes, follow logically from people’s
perceptions of their problems (Leventhal et al. 1992).
Cooper et al. (1999), for example, found that patients
who did not attend cardiac rehabilitation were less
likely than attenders to believe that their condition
was controllable and that their lifestyle might have
contributed to their illness. The non-attending cardiac
patients’ beliefs about their condition did not ﬁt with
the treatment oﬀered. In understanding responses to
physical illnesses, key appraisals concern ideas about
the cause, the length of time the problems will last, the
severity of the consequences, and the degree of control
(Weinman et al. 1996 ; Hagger & Orbell, 2003 ; Petrie
et al. 2007). This framework has now been successfully
applied to understanding emotional adaptation and
quality of life in severe mental health conditions such
as psychosis (Lobban et al. 2004 ; Watson et al. 2006).
In this report, we examine illness beliefs, speciﬁcally
in relation to the successful take-up of psychological
treatment for psychosis.
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Meta-analyses lead to conclusions that cognitive
behaviour therapy (CBT) can reduce the positive
symptoms of psychosis (e.g. Zimmermann et al. 2005 ;
Wykes et al. 2008 ; NICE, 2009), although the eﬀect
sizes in intention-to-treat (ITT) analyses of this ﬁrst
generation of therapies lie in the weak to moderate
range. CBT for psychosis aims to give patients a
better understanding and control of their experiences
to reduce distress and increase functioning. It typically
involves helping people understand the factors caus-
ing their diﬃculties, reviewing and testing unhelpful
beliefs, and implementing more helpful coping tech-
niques (e.g. Fowler et al. 1995).
However, not all clients will engage with CBT,
and not all beneﬁt from it. There have been few reports
of the factors inﬂuencing the take-up of CBT for
psychosis. Lack of ‘ insight ’, that is failure to endorse
the view that a psychiatric illness is present, has
been identiﬁed as aﬀecting therapeutic alliance and
completion of therapy (A´lvarez-Jime´nez et al. 2009 ;
Wittorf et al. 2009 ; Barrowclough et al. 2010). However,
no study has examined patients’ beliefs about their
problems in detail, or considered the use of thera-
peutic strategies during the sessions. We therefore
included the standard instrument for assessing illness
representations, the Illness Perception Questionnaire
(IPQ; Weinman et al. 1996), in the pre-therapy
baseline assessment for the Psychological Prevention
of Relapse in Psychosis (PRP) Trial (Garety et al. 2008 ;
Dunn et al. 2012), a large randomized controlled
trial that compared CBT for psychosis with treatment
as usual.
In this trial there was heterogeneity in take-up
of therapy, and this determined outcome. Taken as a
group, the ITT analysis for the PRP Trial showed that
simply being randomly allocated to CBT resulted in
very little beneﬁt (Garety et al. 2008). However, only
41% of patients allocated to CBT had the more active
types of therapeutic techniques. In a planned analysis
that used structural equation modelling to estimate
ITT eﬀects for subgroups, we demonstrated that
patients receiving full active therapy did extremely
well, spending more months in remission and having
less severe psychotic and aﬀective symptoms than if
they had not had CBT (Dunn et al. 2012). It is import-
ant to emphasize that the analysis demonstrated that
this was not a group who were already likely to have
good outcomes : it was the receipt of therapy that
led to beneﬁts. Comparing treated people who did and
did not have full therapy revealed no diﬀerences, it
was the comparison to the control group that ident-
iﬁed beneﬁts. However, there was a degree of symp-
tomatic deterioration in the 38% of patients who
were maintained in therapy but received only basic
assessment and engagement components without
progressing to active components of therapy
(‘partial therapy’). The remaining 21% of patients re-
ceived no therapy because they did not even attend
sessions.
In this report we consider why individuals
had diﬀerent levels of therapy. It is a direct attempt
to understand one aspect of the ﬁndings of Dunn et al.
(2012). We hypothesized that there would be diﬀer-
ences in illness perceptions between those who went
on to be fully engaged in therapy, those who did not
engage with active therapeutic techniques, and those
who did not attend sessions. Thus, people who beneﬁt
from CBT for psychosis would tend to have more
psychologically orientated views of their problems.
Speciﬁcally, we predicted that clients who engaged
in full therapy and therefore derived symptomatic
beneﬁts would be those with psychological expla-
nations for their diﬃculties and a belief that they
could establish a degree of control over them. Finally,
we examined the role of insight because of the earlier
work indicating an eﬀect on the therapy process
(e.g. Barrowclough et al. 2010).
Method
Participants
This report concerns the 92 PRP Trial participants
who had completed the IPQ (Weinman et al. 1996) at
the pre-randomization baseline assessment, and were
allocated to CBT and subsequently categorized using
ratings of audiotapes by Dunn et al. (2012) as having
had ‘ full therapy’, ‘partial therapy’ or ‘no therapy’.
Therefore, the study explicitly uses the patient classi-
ﬁcations carried out by Dunn et al. (2012) to explain
the take-up of therapy in the trial. Ten out of the
102 patients in the original report had not completed
the IPQ.
The inclusion criteria for trial participants were : a
current clinical diagnosis of non-aﬀective psychosis in
ICD-10 F20–29 (WHO, 1992) and DSM-IV (APA, 1994) ;
age 18–65 years ; a second or subsequent psychotic
episode starting not more than 3 months before they
agreed to enter the trial ; and a rating of at least 4
(moderate severity) for at least one positive symptom
on the Positive and Negative Syndrome Scale (PANSS;
Kay, 1991). Exclusion criteria comprised: a primary
diagnosis of alcohol or substance dependence, organic
syndrome or learning disability ; spoken English
inadequate for engaging in psychological therapy;
and unstable residential arrangements such that the
likelihood of being available for the duration of the
trial was low. Participants provided informed consent
under protocols approved by the appropriate ethics
committees.
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Treatment
CBT was delivered for 9 months, with a planned
minimum of 12 sessions and a maximum of 20 ses-
sions. The therapy was based upon the manual of
Fowler et al. (1995), ampliﬁed to include key aspects
of relapse prevention highlighted in our cognitive
model (Garety et al. 2001). The mean number of
sessions was 14.3 (S.D.=7.8), each session lasting on
average 1 h. Most of the participants received
therapy from ﬁve lead trial therapists, all doctorate
level or equivalent clinical psychologists employed
full time on the trial. Additional cases were seen
by therapists employed by local mental health
services. These therapists were doctoral clinical
psychologists and nurses with specialist training in
CBT for psychosis. Details of recruitment, training
and quality control are provided elsewhere (Garety
et al. 2008).
Formal monitoring of therapy tapes was carried
out throughout the trial. The Revised Cognitive
Therapy for Psychosis Adherence Scale (R-CTPAS;
Rollinson et al. 2008) is a measure of ﬁdelity that
covers 21 cognitive therapy techniques for psychosis.
Dunn et al. (2012) used ratings from the R-CTPAS
to create a classiﬁcation for the therapy received by
each person treated in the trial, and the current report
aims to understand what led to a patient’s particular
classiﬁcation. The classiﬁcation was derived from
factor analysis of the R-CTPAS, which generated two
factors. The ﬁrst, which was termed ‘partial therapy’,
comprised engagement and assessment techniques,
that is attempts to engage in therapeutic strategies ;
the ‘Columbo style ’, which assesses the degree to
which therapists promote guided discovery; and the
collaborative assessment of psychotic experience and
delusional beliefs. The second, termed ‘full therapy’,
comprised active therapy techniques, that is relapse-
prevention interventions ; enhancing self-regulatory
strategies ; developing a personal model of relapse ;
developing a model of psychosis ; work on re-
interpreting the meaning of delusional beliefs and
hallucinations ; and schema work. For full or partial
therapy to be considered present, at least one of
the composite active intervention or engagement and
assessment items needed to be unequivocally present
across the course of therapy. Clients who received
less than ﬁve therapy sessions formed a third, ‘no
therapy’, group, as this number of sessions was
regarded as too small for the delivery of eﬀective CBT.
Categorization of therapy was carried out by the
therapists, who were unaware of the illness perception
data. The latter were collected separately by research
workers, before randomization to therapy. Thirty-
eight participants had full therapy, 36 partial therapy
and a further 18 had less than ﬁve sessions of
therapy, thus falling into the no therapy group. It
should be emphasized that partial therapy met the
deﬁnition of highly competent cognitive therapy
(in terms of the use of appropriate engagement
and assessment skills), and was observed to be ac-
companied by attempts by the therapists to introduce
and deliver the techniques of full therapy as well.
Furthermore, the therapists had not simply classiﬁed
the groups by their observed outcomes because
there were no diﬀerences in the follow-up symptom
measure scores between the full, partial or no therapy
groups (Dunn et al. 2012). The signiﬁcant outcome
results only emerged from the comparison with
the appropriate patients in the control group (and
therefore could not have been observed by the
therapists).
Measures
The main measure reported here is the IPQ modiﬁed
and validated for psychosis (Weinman et al. 1996 ;
Watson et al. 2006). It was administered before trial
randomization (and therefore before therapy). The
IPQ assesses ﬁve main constructs : symptoms, causes,
consequences, cure/control and timeline. For psy-
chosis, the symptoms scale comprised six positive
symptoms: (i) seeing images ; (ii) feeling confused;
(iii) hearing voices ; (iv) having paranoid thoughts ;
(v) holding beliefs not shared by others ; and (vi) feel-
ing that one’s mind is being controlled. For each
item, the response format was 0–3, with a score of 0
representing ‘never ’ and 3 representing ‘all the time’.
Higher scores therefore indicate more symptoms.
Eleven causes of psychosis are listed (e.g. ‘A germ or
virus caused my current problems/illness ’). The ﬁve-
point scale for each putative cause was dichotomized
into ‘agree’ (strongly agree, agree) and ‘not agree’
(neither agree nor disagree, disagree, strongly dis-
agree) ; we were interested in whether a particular
causal belief was present and not how strongly it was
held. The consequences (e.g. ‘My current problems/
illness have had major consequences on my life ’),
timeline (e.g. ‘My current problems/illness will last
a long time’) and cure/control (e.g. ‘There is a lot
which I can do to control my symptoms’) constructs
were measured by seven, three and six items respect-
ively. Each of these IPQ items was measured on a
scale of 1–5, from strongly disagree to strongly agree.
Higher scores represent greater perceived conse-
quences, longer duration of problems and greater
feelings of control. All questions were worded as
referring to ‘problems/illness ’ so that they could be
completed by clients who did not believe that they had
an illness.
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Psychiatric symptoms were assessed with the
PANSS (Kay, 1991) and the Beck Depression Inventory
(BDI ; Beck et al. 1996). Insight was measured using the
‘awareness of mental disorder ’ item of the Scale to
Assess Unawareness of Mental Disorder (Amador
et al. 1993).
Statistical analysis
All analyses were conducted using SPSS 15.0 (2006).
Group comparisons (no therapy, partial therapy, full
therapy) for dichotomous variables were carried out
using x2 tests. Where there was an overall group
eﬀect, further comparisons of the groups were made.
Group comparisons on the dimensional measures
were carried out using analysis of variance (ANOVA)
When the result of the ANOVA was signiﬁcant,
least signiﬁcant post-hoc tests are reported. Finally, the
ability of the IPQ to predict group membership was
examined. A linear discriminant analysis was carried
out, entering IPQ variables previously identiﬁed in
the analysis as signiﬁcant. All hypothesis testing was
two-tailed.
Results
Demographic and clinical characteristics
Basic demographic and clinical information about
the study participants is presented in Table 1.
Participants tended to be male, unemployed, single
and in their late thirties. The majority had a diagnosis
of schizophrenia and had been admitted to psychiatric
hospital on several occasions. The three therapy
groups did not diﬀer signiﬁcantly in duration of
Table 1. Demographic and basic clinical information
No
therapy
Partial
therapy
Full
therapy
Age (years) 38.1 (12.5) 39.8 (10.4) 39.5 (9.2)
Sex
Male 14 23 30
Female 4 13 8
Ethnicity
White 12 23 28
Black-Caribbean 0 7 1
Black-African 3 2 3
Indian 1 1 2
Other 2 3 4
Employment
Employed 1 4 0
Employed part-time 0 1 0
Voluntary employment 1 0 5
Unemployed 15 31 30
Housewife/husband 1 0 1
Student 0 0 1
Unknown 0 0 1
Marital status
Single 12 24 26
Married 2 5 4
Divorced/separated 4 7 7
Widowed 0 0 1
Diagnosis
Schizophrenia 15 34 33
Schizo-aﬀective disorder 3 1 3
Delusional disorder 0 1 2
Hospital status at relapse
In-patient 9 22 28
Out-patient 9 14 10
Duration of illness (years) 7.7 (7.0) 11.4 (8.0) 12.0 (8.3)
Number of hospital admissions 3.7 (4.8) 5.3 (7.8) 4.3 (2.8)
Values given as number or mean (standard deviation).
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illness (F2,88=1.95, p=0.149) or number of hospital
admissions (F2,85=0.53, p=0.590). There were no
diﬀerences between the groups in current levels
of symptoms, whether assessed by the PANSS, BDI or
by IPQ-Symptoms (see Table 3).
The perceived cause of problems
The groups diﬀered signiﬁcantly in their endorsement
of three causes on the IPQ: state of mind, personality
and pollution (Table 2). The full therapy group en-
dorsed personality as a cause more than the partial
therapy group [x2(df=1)=5.89, p=0.015] and the no
therapy group [x2(df=1)=3.88, p=0.049]. The full
therapy group endorsed state of mind as a cause
more than the partial therapy group [x2(df=1)=8.83,
p=0.003] but not signiﬁcantly more than the no ther-
apy group [x2(df=1)=2.23, p=0.135]. Those in the
partial therapy group were more likely to endorse
pollution as a cause compared with the full therapy
group [x2(df=1)=5.62, p=0.018] and the no therapy
group [x2(df=1)=4.02, p=0.045].
Perceived consequences, cure/control, timing
and insight
The three groups did not signiﬁcantly diﬀer in
their estimates of the consequences of their problems
Table 2. Illness Perception Questionnaire (IPQ) – causes
Cause
Level of therapy, n (%)
x2 (df=2) p valueNone Partial Full
State of mind
Agree 12 (67) 17 (52) 32 (84)
Disagree 6 16 6 8.79 0.012
Personality
Agree 9 (50) 16 (48) 29 (76)
Disagree 9 17 9 6.81 0.033
Stress
Agree 13 (72) 22 (65) 30 (79)
Disagree 5 12 8 1.81 0.404
Own behaviour
Agree 8 (44) 10 (29) 19 (50)
Disagree 10 24 19 3.25 0.197
Other people
Agree 11 (61) 23 (68) 24 (63)
Disagree 7 11 14 0.27 0.875
Pollution
Agree 1 (6) 10 (29) 3 (8)
Disagree 17 24 35 8.04 0.018
Germ
Agree 3 (17) 9 (26) 7 (18)
Disagree 15 25 31 0.97 0.617
Hereditary
Agree 3 (17) 10 (29) 10 (26)
Disagree 15 24 28 1.02 0.599
Chance
Agree 7 (39) 15 (45) 11 (29)
Disagree 11 18 27 2.09 0.351
Poor medical care
Agree 6 (33) 14 (42) 10 (26)
Disagree 12 19 28 2.05 0.358
Diet
Agree 5 (28) 7 (20) 10 (26)
Disagree 13 26 28 0.36 0.835
df, Degrees of freedom.
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or in their degree of insight (Table 3). However, those
in the no therapy group were signiﬁcantly less likely
to perceive their problems as long-lasting than both
the partial therapy (p=0.043) and the full therapy
groups (p=0.007). In addition, the partial therapy
group scored signiﬁcantly lower on the dimension of
cure/control than the no therapy group (p=0.012) and
the full therapy group (p=0.007).
Predicting group membership
The ﬁve signiﬁcant IPQ variables (state of mind,
personality, pollution, cure/control, timing) were
entered into a linear discriminant function analysis ;
58.1% cases were classiﬁed correctly. Prediction of
the full therapy group (64.9%) was higher than for
the partial therapy (54.8%) and no therapy (50.0%)
groups. Of note, those in the no therapy group
were more likely to be misclassiﬁed as being in the
full therapy group than in the partial therapy group
(Table 4). A logistic discrimination analysis produced
similar results.
Discussion
For clinicians practicing in the area, the variability in
how CBT for psychosis proceeds is very clear. Some
patients do not attend their appointments, in some
instances regular attendance alone seems an achieve-
ment, and only in a proportion of cases does the
Table 3. IPQ dimensional scores, insight and psychiatric symptoms
Measure n Mean S.D. F df p value
IPQ – Symptoms
No therapy 18 6.78 4.29
Partial therapy 36 8.25 4.83
Full therapy 38 6.79 4.07 1.20 2, 89 0.306
IPQ – Consequences
No therapy 18 25.83 4.74
Partial therapy 33 26.12 4.53
Full therapy 35 26.50 3.48 0.173 2, 86 0.841
IPQ – Timeline
No therapy 18 8.44 3.58
Partial therapy 34 10.29 3.00
Full therapy 38 10.89 2.90 3.90 2, 87 0.024
IPQ – Cure/Control
No therapy 18 22.17 4.25
Partial therapy 34 19.12 3.98
Full therapy 37 21.76 4.03 4.97 2, 86 0.009
Insight
No therapy 18 2.67 1.24
Partial therapy 36 3.17 1.48
Full therapy 38 2.45 1.61 2.20 2, 89 0.117
Total PANSS score
No therapy 18 64.22 15.77
Partial therapy 36 66.00 12.20
Full therapy 38 63.63 13.59 0.30 2, 89 0.744
PANSS positive score
No therapy 18 19.11 5.21
Partial therapy 36 18.19 5.05
Full therapy 38 17.08 4.99 1.08 2, 89 0.344
BDI score
No therapy 18 21.61 12.62
Partial therapy 36 23.50 12.11
Full therapy 38 21.87 10.53 0.24 2, 89 0.785
IPQ, Illness Perception Questionnaire ; PANSS, Positive and Negative Syndrome
Scale ; BDI, Beck Depression Inventory ; S.D., standard deviation ; df, degrees of
freedom.
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collaboration lead to active adoption of new ways of
thinking and behaving. In standard CBT for psychosis
we know that only the latter instances lead to
measurable beneﬁt. This is the ﬁrst study to examine
patient characteristics that predict beneﬁcial use of
CBT for problems associated with psychosis. It is im-
portant to highlight that neither the level of symptoms
nor the acknowledgement of the presence of a psy-
chiatric illness (or ‘ insight ’) determined take-up of
therapy; these standard psychiatric assessments did
not illuminate response to psychological therapy.
Instead, there were indications that the contributory
factors may be what the person thought caused their
problems, how long they thought the problem would
last, and whether the degree of control they believed
that they had seemed important. Illness represen-
tations predicted, to some extent, take-up of treatment,
just as has been found for many other conditions
(McAndrew et al. 2008). Successful intervention is
more likely when there is alignment between patients’
ideas about their problems and the conceptual basis of
the treatment approach.
The individuals who did not attend therapy typi-
cally thought that their problems would persist for
less time than those who arrived for sessions. The non-
attenders may have thought that there was less
need for therapy, although it is of note that this was
still a group with signiﬁcant diﬃculties that had
already required an average of four psychiatric ad-
missions. Overoptimistic expectations of the duration
of problems may be an important factor here. The non-
attenders were also less likely to endorse psychologi-
cal explanations of cause than those who had full
therapy. Once clients were attending sessions, prog-
ress was facilitated if they believed they had more
control over their problems, that their own psycho-
logical make-up contributed to the problems, and that
unchangeable causal factors (e.g. pollution) were
relatively unimportant. Indeed, the deterioration in
the partial group may be accounted for by a clash be-
tween the underlying principles of therapy and the
patients’ ideas about their problems. Conversely, once
a person was attending sessions, having psychological
ideas about the cause of the problems and a sense
that they could have control enabled full take-up of
CBT. It seems that individuals could work with the
therapists when they held the view that their own-
behaviour was important in contributing to the prob-
lems and that they could, to an extent, assert control.
Of note, the non-attenders and the full therapy groups
were more like each other than the partial therapy
group. The non-attenders had a sense of control and
some psychological explanations for their problems,
but clearly they decided not to choose therapy as the
way to help themselves.
Illness perceptions were only at best a moderate
predictor of the groups. Our results do not mean that
we can accurately predict who will derive most beneﬁt
from being oﬀered CBT. Nor at this stage of the de-
velopment of CBT for psychosis should that occur. The
intervention itself is evolving, becoming more theor-
etically driven, targeted and problem focused (e.g.
Trower et al. 2004 ; Freeman et al. 2008; Foster et al.
2010 ; Freeman, 2011 ; Hepworth et al. 2011 ; Myers et al.
2011 ; Ross et al. 2011). These ﬁndings indicate further
that it is likely that techniques for encouraging more
adaptive illness beliefs should be incorporated into
therapy (e.g. Petrie et al. 2002; McAndrew et al. 2008).
Thus, in the early stages of therapy the clinician might
explicitly focus on, for example, beliefs about control.
Such ideas may then be actively reviewed and tested.
Clearly, other factors such as therapist attributes are
likely to be important too. Work on treatment adher-
ence has focused on beliefs about treatment as a key
determinant (Horne & Weinman, 1999), showing the
importance of the ﬁt between beliefs about treatment
and those about illness. Patients form their ideas
about, and their response to, treatment (including ad-
herence) in terms of their current illness model (Horne
& Weinman, 2002; Llewellyn et al. 2003). Thus, future
studies should include a measure of patients’ beliefs
about the treatment (Horne et al. 1999).
Research on this topic is labour intensive and
requires large samples to examine the diﬀerent out-
comes. Our study included 92 patients but still
lacks statistical power, especially in the face of mul-
tiple statistical testing. Type 1 error may be seen
in the results. Moreover, the classiﬁcation rate of
approximately 60% was determined from the same
sample used in the derivation of the classiﬁcation
rule. This is likely to overestimate the success of pre-
diction. A further weakness is that, in the assessment
of illness representations, the causes were listed for
the interviewees and there was no attempt to obtain
respondent-generated responses. We therefore may
not have been tapping the causes most pertinent to
individuals. It would also be valuable to understand
more about the origins of illness representations.
Table 4. Linear discriminant function analysis
Original
group
membership
Predicted group membership (%)
No
therapy
Partial
therapy
Full
therapy
No therapy 50.0 13.7 33.3
Partial therapy 22.6 54.8 22.6
Full therapy 16.2 18.9 64.9
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Future studies should use the revised IPQ (Moss-
Morris et al. 2002) because this separates beliefs
about treatment control from personal control, and
also allows investigators to assess additional illness-
related beliefs, such as coherence and emotional
impact.
In summary, the key clinical implication of the
study is the potential informativeness of illness per-
ceptions in the therapeutic context. These may provide
an indicator of the potential progress of therapy,
although replication of these ﬁndings for the psycho-
logical treatment of psychosis is clearly necessary. It is
likely that encouraging and highlighting the degree to
which patients have control will beneﬁt them clinically
and facilitate engagement with other therapeutic
techniques. In the development of psychological ap-
proaches to psychosis, the study of illness perceptions
and readiness to change may open a valuable area of
future research.
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